Logo
Aliaxin® SV

Aliaxin® SV

Aliaxin

Medical aesthetic product
  • CE Marked Class III medical device
Dermal filler \u2014 hyaluronic acid (volume & contouring)

Description

Aliaxin® SV (Superior Volume) is a highly cross-linked monophasic hyaluronic acid dermal filler from IBSA, engineered for advanced volumisation and structural contouring of the cheeks, jawline and chin. Its elevated cross-linking ratio delivers strong lifting capacity, making it ideal for correcting severe sagging and very deep wrinkles. The gel integrates smoothly with surrounding tissues, ensuring balanced and natural facial definition with long-lasting results. Created for practitioners seeking powerful yet refined volume enhancement solutions.

Bnefits

  • Designed for high-volume restoration and contouring of cheeks, jawline and chin.
  • Effectively corrects severe sagging and very deep wrinkles.
  • Provides strong lifting action due to high cross-linking rate.
  • Monophasic HA gel ensures smooth tissue integration for natural results.
  • Improves severe facial hollowing and enhances structural facial definition.
  • Non-animal, ultrapure hyaluronic acid ensuring biocompatibility and safety.
  • Perfect for patients seeking dramatic but natural volumising outcomes.

Indications

  • Cheek volumisation and contouring.
  • Jawline definition.
  • Chin augmentation.
  • Very deep wrinkles (e.g., deep nasolabial folds).
  • Severe facial sagging.
  • Volume loss due to ageing or facial asymmetry.
  • Areas requiring substantial enhancement for structural support.

Composition

  • Cross-linked hyaluronic acid 25 mg/ml (non-animal, biofermented).
  • Physiological buffer solution.
  • No lidocaine included.
  • Ultrapure HA produced using IBSA’s patented bio-fermentation process.

Formulation

  • Monophasic high-viscosity hyaluronic acid gel.
  • High cross-linking ratio for enhanced lifting and structural support.
  • Apyrogenic, sterile physiological HA-based dermal filler.
  • Designed to integrate seamlessly into subcutaneous tissues.

Packaging

  • 2 × 1 ml pre-filled sterile syringes.
  • Sterile, single-use packaging.
  • Traceability labels included.
  • Sterile needles included (typically 27G or similar, depending on region).
  • Full IFU (instructions for use).

Usage

  • For use only by qualified and medically trained professionals.
  • Inject into subcutaneous tissue or deep dermal layers depending on treatment goals.
  • Intradermal application is required as per manufacturer guidance.
  • Use appropriate injection techniques such as linear threading, fanning or bolus placement.
  • Assess facial anatomy before injecting to avoid vascular risk zones.
  • Avoid overcorrection; product continues to integrate after injection.
  • Advise patients to avoid heat, alcohol, strenuous exercise and manipulation of treated areas for at least 24 hours.

Contraindications

  • Hypersensitivity to hyaluronic acid.
  • Active infections or inflammation at injection sites.
  • Pregnancy or breastfeeding.
  • Autoimmune disorders (clinician discretion).
  • History of severe allergic reactions or anaphylaxis.
  • Patients under 18 years of age.

Adverse Effects

  • Temporary redness and swelling.
  • Injection-site tenderness or pain.
  • Bruising or hematoma formation.
  • Itching or minor lumpiness.
  • Rare: vascular occlusion, nodules, necrosis or infection.

Storage Conditions

  • Store between 2°C and 25°C.
  • Do not freeze.
  • Keep syringes in original packaging away from direct light.
  • Do not use after expiry date.

Duration

Approximately 6\u201312 months depending on patient metabolism, treatment area and product volume.

Onset

Immediate

Browse more Medical aesthetic product

Top Treatments

Top Cities in the UK